Public Assesment Report For CA Of Pharmaceutical product
Public Assessment Reports (PARs) provide a summary of the scientific evaluation conducted by the Egyptian Drug Authority (EDA) for applications that have completed the review process, as part of the Authority's commitment to promoting regulatory transparency.
These reports are intended to explain the scientific and regulatory basis underpinning the Authority's decisions by providing an overview of the data evaluated and the key findings related to quality, safety, and efficacy.
This include two Types Of PAR